256 related articles for article (PubMed ID: 11343755)
1. Drug firms lose patent rights lawsuit against South Africa's government.
Baleta A
Lancet; 2001 Apr; 357(9265):1347. PubMed ID: 11343755
[No Abstract] [Full Text] [Related]
2. South Africa's moral victory.
Lancet; 2001 Apr; 357(9265):1303. PubMed ID: 11343727
[No Abstract] [Full Text] [Related]
3. Drug firms take South Africa's government to court.
Baleta A
Lancet; 2001 Mar; 357(9258):775. PubMed ID: 11253978
[No Abstract] [Full Text] [Related]
4. Drug firms drop drug case against South Africa.
AIDS Policy Law; 2001 May; 16(9):3. PubMed ID: 11668825
[No Abstract] [Full Text] [Related]
5. Canada to change patent law to allow export of cheap drugs.
Kondro W
Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
[No Abstract] [Full Text] [Related]
6. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
Halliburton M
Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
[TBL] [Abstract][Full Text] [Related]
7. The role of civil society in protecting public health over commercial interests: lessons from Thailand.
Ford N; Wilson D; Bunjumnong O; von Schoen Angerer T
Lancet; 2004 Feb; 363(9408):560-3. PubMed ID: 14975620
[No Abstract] [Full Text] [Related]
8. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
9. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti AM
Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
[No Abstract] [Full Text] [Related]
10. [The patent legislation in India fails the HIV/AIDS work].
Holen Ø
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
[No Abstract] [Full Text] [Related]
11. World trade rules and cheaper drugs.
Lancet; 2001 Jan; 357(9252):243. PubMed ID: 11214119
[No Abstract] [Full Text] [Related]
12. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
13. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
14. In the high court of South Africa, case no. 4138/98: the global politics of access to low-cost AIDS drugs in poor countries.
Barnard D
Kennedy Inst Ethics J; 2002 Jun; 12(2):159-74. PubMed ID: 12476916
[TBL] [Abstract][Full Text] [Related]
15. Medicines for all, not just the rich.
Davey S
Bull World Health Organ; 2001; 79(4):377-8. PubMed ID: 11357220
[No Abstract] [Full Text] [Related]
16. Access to essential drugs, human rights and global justice.
Shalev C
Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
[No Abstract] [Full Text] [Related]
17. Brazil and USA at loggerheads over production of generic antiretrovirals.
Ahmad K
Lancet; 2001 Feb; 357(9254):453. PubMed ID: 11273079
[No Abstract] [Full Text] [Related]
18. TRIPS: generic irony.
Howarth GR
Br J Gen Pract; 2002 Jan; 52(474):57. PubMed ID: 11791819
[No Abstract] [Full Text] [Related]
19. Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?
Gostin LO; Rai AK
JAMA; 2020 Mar; 323(9):821-822. PubMed ID: 32125411
[No Abstract] [Full Text] [Related]
20. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
Nderitu T
E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
